Dr. Chiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# 141
New York, NY 10065Phone+1 212-746-6000Fax+1 646-962-0122
Summary
- NIH-funded physician-scientist developing PET and MR imaging tools to better diagnose and monitor Alzheimer's and other neurodegenerative diseases.
Education & Training
University of California (San Francisco)Fellowship, Neuroradiology, 2011 - 2012- University of California (San Francisco)Residency, Radiology-Diagnostic, 2007 - 2011
Santa Clara Valley Medical CenterInternship, Transitional Year, 2006 - 2007
Harvard Medical SchoolClass of 2006
Princeton UniversityAB, Highest Honors, 1998 - 2002
Certifications & Licensure
NY State Medical License 2012 - 2025
CA State Medical License 2008 - 2012- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Neuroradiology
Publications & Presentations
PubMed
- Utilizing structural MRI and unsupervised clustering to differentiate schizophrenia and Alzheimer's disease in late-onset psychosis.Seyed Hani Hojjati, Kewei Chen, Gloria C Chiang, Amy Kuceyeski, Xiuyuan H Wang
Behavioural Brain Research. 2024-12-05 - Increased between-network connectivity: A risk factor for tau elevation and disease progression.Seyed Hani Hojjati, Tracy A Butler, José A Luchsinger, Richard Benitez, Mony de Leon
Neuroscience Letters. 2024-09-25 - Hybrid PET/MRI in Neurodegenerative Disorders.Graham Keir, Yi Li, Gloria Chiang
Advances in Clinical Radiology. 2024-09-01
Press Mentions
Grant to Develop Portable PET Scanner for Alzheimer’s DiseaseNovember 5th, 2024
Grant to Help Develop Portable PET Scanner for Alzheimer’sNovember 5th, 2024
A New Spectrum of Biomarkers Emerges for Alzheimer's DiseaseMay 28th, 2024- Join now to see all
Grant Support
- Quantitative Susceptibility Mapping (QSM) as a non-invasive imaging biomarker for predicting neurodegeneration in Alzheimer's DiseaseNational Institutes of Health-National Institute on Aging2020–2022
- Prism-PET/EMMT: High resolution, cost effective, portable, and upright brain PET scanner for early diagnosis of Alzheimer's disease (U01)NIH-NIAPresent
- Tau progression index (TPI): An individualized predictor of Alzheimer's Disease trajectory based on subject-specific connectomes (R01)NIH-NIAPresent
- Quantitative MRI-based cerebral oxygen metabolism in Alzheimer's diseaseNational Institutes of Health - National Institute on AgingPresent
- The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderlyNational Institutes of Health - National Institute on AgingPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
